These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6167556)

  • 41. A new HLA-D specificity associated with DR blank: D-BON.
    Cambon-Thomsen A; Thomsen M; Abbal M; Sommer E; Calot M; Ohayon E
    Tissue Antigens; 1986 May; 27(5):256-61. PubMed ID: 2941896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-DR2 and DR4 further defined by two new HLA-D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations.
    Mickelson E; Brautbar C; Nisperos B; Cohen N; Amar A; Kim SJ; Lanier A; Hansen JA
    Tissue Antigens; 1984 Sep; 24(3):197-205. PubMed ID: 6334906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of HLA segregation in 479 thalassemic families.
    Contu L; Arras M; Mulargia M; La Nasa G; Carcassi C; Leone AL; Ledda A; Goddi F
    Tissue Antigens; 1992 Feb; 39(2):58-67. PubMed ID: 1574799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MLC (HLA-D) typing: a family study.
    Jørgensen F; Kristensen T; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1977 Nov; 10(5):379-93. PubMed ID: 75583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-D clusters associated with DR2 and the definition of HLA-D"AZH": a new DR2 related HLA-D specificity in Israel.
    Cohen N; Amar A; Oksenberg JR; Brautbar C
    Tissue Antigens; 1984 Jul; 24(1):1-9. PubMed ID: 6207623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families.
    Said-Nahal R; Miceli-Richard C; Gautreau C; Tamouza R; Borot N; Porcher R; Charron D; Dougados M; Breban M
    Ann Rheum Dis; 2002 Mar; 61(3):201-6. PubMed ID: 11830423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA frequencies in a Mexican Mestizo population.
    Gorodezky C; Terán L; Escobar-Gutiérrez A
    Tissue Antigens; 1979 Oct; 14(4):347-52. PubMed ID: 94707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA haplotype sharing by siblings with rheumatoid arthritis: evidence for genetic heterogeneity.
    Grennan DM; Sanders PA; Dyer PA; Harris R
    Ann Rheum Dis; 1986 Feb; 45(2):126-9. PubMed ID: 3484935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statistical methods for studying homozygous typing cells of unknown specificity.
    Mendell NR; Johnson AH; Ward FE; Hartzman RJ; Phillips EA; Ayres J; Amos DB; Ciftan EA
    Hum Immunol; 1981 Mar; 2(2):125-38. PubMed ID: 6167555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-D typing with lymphoblastoid cell lines. VI. Rationale and goals of data reduction.
    Gatti RA; Kemple K; Schwartzmann J; Leibold W
    Tissue Antigens; 1979 Sep; 14(3):183-93. PubMed ID: 230611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two homozygous typing cells defining a subgroup of HLA-Dw6.
    Mickelson EM; Nisperos B; Hansen JA
    Hum Immunol; 1980 Dec; 1(4):363-8. PubMed ID: 6167553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities.
    Tanigaki N; Tosi R; Centis D; Ferrara GB; Pressman D
    Hum Immunol; 1981 Oct; 3(2):93-108. PubMed ID: 6173362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity.
    Dubey DP; Alper CA; Mirza NM; Awdeh Z; Yunis EJ
    J Exp Med; 1994 Apr; 179(4):1193-203. PubMed ID: 8145038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-D antigens in a Czech population and their association with HLA-DR antigens.
    Hinzová E; Ivasková E; Cukrová V; Rychlíková M
    Folia Biol (Praha); 1980; 26(4):267-74. PubMed ID: 6773825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2.
    Hirayama K; Nishimura Y; Tsukamoto K; Sasazuki T
    J Immunol; 1986 Aug; 137(3):924-33. PubMed ID: 2424990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the HLA--D determinants in the Hungarian population.
    Onody C; Kristensen T; Lamm LU; Gyódi E; Petrány GG; Bátory G; Nemeskéry J
    Tissue Antigens; 1978 Nov; 12(5):323-9. PubMed ID: 85348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.